Aptamers Market: By Aptamers Type (Nucleic acid aptamers, RNA-based, XNA-based, DNA-based, Peptide aptamers), By Application (Research & Development, Therapeutic development, Diagnostics), By End User (Pharmaceutical companies, Biopharmaceutical companies, Research and academic institutes, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Aptamers Market size was USD 252.3 million in 2022 and is poised to grow at a CAGR of 16.89% from 2023-2029. owing to rise in the investment in biotechnology and pharmaceutical companies for R&D activities, technological developments, an increase in the therapeutic application anticipated to fuel the aptamers market over the forecast period. Furthermore, increase in the using of aptamers in metabolism drug discovery, entry of private organizations in research and development space, and advantages of aptamers over other rna therapeutics expected to drive the market. However, stringent regulatory policies and ethical issues in aptamers usage, dearth of aptamers in the market in the undeveloped regions, and lack of awareness about the aptamers usage expected to dampen the growth of aptamers market over the forecast period. Aptamers are the single-stranded peptide or oligonucleotide molecules that bind to the protein, nucleic acid molecules or target lipid with the high specificity. Aptamers are used in pharmaceutical studies, laboratory diagnosis, drug discovery, molecular recognition, and treatment of certain diseases.

In addition, aptamers are also used in the production of cost-effective and improved medicines, the advantages of aptamers over protein therapeutics include in terms of synthetic accessibility, modification, and size. Aptamers are commonly used in the treatment of AIDS owing to faster development than the antibodies which lead to curing of diseases very faster. Aptamers are single-stranded DNA and RNA molecules that can bind to a specific target with high specificity. Aptamers come in a range of forms thanks to their proclivity for forming helices and single-stranded loops. These can be made fast and used to inhibit and characterise proteins, and they can also be designed to have improved specificity and affinity. These flexible compounds bind to a variety of targets, including proteins, peptides, small molecules, toxins, carbohydrates, and even live cells. Aptamers are usually produced through a selection process from a vast pool of random sequences, and they can be used in both therapeutic and scientific settings.

Global Aptamers Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

16.89%

Largest Market

North America

Fastest Growing Market

Europe
Aptamers Market Dynamics

Nowadays, Aptamers market is the growing stage with an increase in R&D activities by the various biopharmaceutical companies and research institutes. Technological advancements and drug innovations are expected to fuel the market. For instance, in 2014, MIT scientists created DNA-based drug targeting system comprising of aptamers and ultraviolet light which leads to binding of aptamers with high specificity. Acquisitions and mergers, collaborations, newer technologies launches, fundraising for aptamers development and patent approvals are some key strategies adopted by the companies to increase their share in the global market. For instance, in February 2012, Valent pharmaceutical acquired Eyetech and enters into the aptamers market with the marketing of Macugen anti-VEGF aptamers in U.S. Moreover, in February 2016, researchers from Institute of Bioengineering and Nanotechnology (Singapore) have developed more efficient DNA technology for detection and treatment of cancer and infectious diseases.

Global Aptamers Market Segmentation

By Aptamers Type
  • Nucleic acid aptamers
  • RNA-based
  • XNA-based
  • DNA-based
  • Peptide aptamers
By Application
  • Research & Development
  • Therapeutic development
  • Diagnostics
By End User
  • Pharmaceutical companies
  • Biopharmaceutical companies
  • Research and academic institutes
  • Others

Frequently Asked Questions

The aptamers market size was valued at USD 252.3 million in 2022

High Advantage of Aptamers, Compared to Antibodies

Europe is the fastest-growing for aptamers market

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  1. Executive Summary
  2. Global Aptamers Market Introduction
    • Global Aptamers Market Taxonomy
    • Global Aptamers Market Definitions
      • Aptamers Type
      • Application
  1. Global Aptamers Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Aptamers Market Dynamic Factors - Impact Analysis
    • Global Aptamers Market Competition Landscape
    • Epidemiology
  2. Global Aptamers Market Analysis,2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Aptamers Market, By Aptamers Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Nucleic acid aptamers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • RNA-based
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • XNA-based
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • DNA-based
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Peptide aptamers
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Aptamers Market Forecast, By Application,2018 - 2022 and Forecast, 2023 - 2029
    • Research & Development
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Therapeutic development
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostics
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Aptamers Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Pharmaceutical companies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Biopharmaceutical companies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Research and academic institutes
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Aptamers Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Aptamers Market - Opportunity Analysis Index, By Aptamers Type, By Application, By End User and Region, 2023 - 2029
  2. North America Aptamers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Aptamers Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Nucleic acid aptamers
      • RNA-based
      • XNA-based
      • DNA-based
      • Peptide aptamers
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Research & Development
      • Therapeutic development
      • Diagnostics
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical companies
      • Biopharmaceutical companies
      • Research and academic institutes
      • Others
    • Country Analysis 2016 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US
      • Canada
    • North America Aptamers Market - Opportunity Analysis Index, By Aptamers Type, By Application, By End User and Country, 2023 - 2029
    • North America Aptamers Market Dynamics Trends
  3. Europe Aptamers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Aptamers Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Nucleic acid aptamers
      • RNA-based
      • XNA-based
      • DNA-based
      • Peptide aptamers
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Research & Development
      • Therapeutic development
      • Diagnostics
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical companies
      • Biopharmaceutical companies
      • Research and academic institutes
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Aptamers Market - Opportunity Analysis Index, By Aptamers Type, By Application, By End User and Country,2023 - 2029
    • Europe Aptamers Market Dynamics Trends
  4. Asia-Pacific Aptamers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Aptamers Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Nucleic acid aptamers
      • RNA-based
      • XNA-based
      • DNA-based
      • Peptide aptamers
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Research & Development
      • Therapeutic development
      • Diagnostics
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical companies
      • Biopharmaceutical companies
      • Research and academic institutes
      • Others
    • Country Analysis2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Aptamers Market - Opportunity Analysis Index, By Aptamers Type, By Application, By End User, and Country,2023 - 2029
    • Asia-Pacific Aptamers Market Dynamics Trends
  5. Latin America Aptamers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Aptamers Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Nucleic acid aptamers
      • RNA-based
      • XNA-based
      • DNA-based
      • Peptide aptamers
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Research & Development
      • Therapeutic development
      • Diagnostics
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical companies
      • Biopharmaceutical companies
      • Research and academic institutes
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Aptamers Market - Opportunity Analysis Index, By Aptamers Type, By Application, By End User and Country,2023 - 2029
    • Latin America Aptamers Market Dynamics Trends
  6. Middle East and Africa Aptamers Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Aptamers Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • Nucleic acid aptamers
      • RNA-based
      • XNA-based
      • DNA-based
      • Peptide aptamers
    • Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Research & Development
      • Therapeutic development
      • Diagnostics
    • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Pharmaceutical companies
      • Biopharmaceutical companies
      • Research and academic institutes
      • Others
    • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Aptamers Market - Opportunity Analysis Index, By Aptamers Type, By Application, By End User and Country,2023 - 2029
    • MEA Aptamers Market Dynamics Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Aptamers Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • NeoVentures Biotechnology, Inc. (Canada)
      • Aptagen, LLC (U.S.)
      • Aptamer Solutions Ltd. (U.K.)
      • SomaLogic, Inc. (U.S.)
      • AM Biotechnologies, LLC (U.S.)
      • TriLink BioTechnologies, Inc. (U.S.)
      • Vivonics, Inc. (U.S.)
      • Apta Targets (Spain)
  1. Research Methodology
  2. Key Assumptions and Acronyms
  • NeoVentures Biotechnology, Inc. (Canada),
  • Aptagen, LLC (U.S.),
  • Aptamer Solutions Ltd. (U.K.),
  • SomaLogic, Inc. (U.S.),
  • AM Biotechnologies, LLC (U.S.),
  • TriLink BioTechnologies, Inc. (U.S.),
  • Vivonics, Inc. (U.S.),
  • Apta Targets (Spain)

Adjacent Markets